Supported by

Stents, scaffolds and DCB

Find all the latest content on stents and scaffolds published on this website.

Since 1986, when the first cardiovascular stent was implanted, the development of drug-eluting stents (DES) and the recent introduction of bioresorbable scaffolds have revolutionised interventional cardiology. Keep up-to-date with the latest research; evolving tools, devices and techniques; the role of adjunctive pharmacotherapy; advances in imaging techniques as well as the use of invasive imaging and functional assessment. Find out more…

Filtered By
Stents, scaffolds and DCB

543 results

T-PASS: Less than 1-month DAPT followed by ticagrelor monotherapy after DES Implantation for ACS

26 Oct 2023

Ali Nazmi Calik interviews Myeong-Ki Hong about the results of the T-Pass randomised trial which he presented during the #TCT Congress 2023 in San Francisco.

Myeong-Ki Hong

Author

Myeong-Ki Hong

Author

Ali Nazmi Calik
T-PASS: Less than 1-month DAPT followed by ticagrelor monotherapy after DES Implantation for ACS

PCRonline @ TCT 2023 - Get the international perspective!

17 Oct 2023

Thanks to the contribution of our team of interventional cardiologists from around the globe, view the international perspective on Late-breaking Clinical Trials and Science to be released at TCT 2023 - check out the list here!

PCRonline @ TCT 2023 - get the international perspective!

Leave nothing behind: DCB-only PCI strategy - How DCB evidence has changed today's practice?

22 Sep 2023 – From AICT-AsiaPCR 2023

This session offers an opportunity to stay informed about the recent developments in the International DCB Consensus Group, gain insights into the latest clinical data and real-world experiences related to drug-coated balloon (DCB)-only PCI, understand the safety aspects of DCB in managing complex PCI cases, and...

Leave nothing behind DCB-only PCI strategy evidence changed today practice

A hybrid approach in complex PCI: can DES and DCB be complementary?

21 Sep 2023 – From AICT-AsiaPCR 2023

Watch this case-based session to follow discussion about how to choose between DES & DCB,  how both can be complementary in diffuse disease as well as in complex PCI, and how physiology and imaging can help guiding PCI, and follow a patient's treatment live.

A hybrid approach in

PCRonline @ ESC Congress 2023: the interventional cardiology perspective!

07 Aug 2023

What was new and hot in interventional cardiology at #ESCCongress 2023!

PCRonline @ ESC Congress 2023

Three-year results of HOST-POLYTECH-ACS RCT comparing durable- vs. degradable-polymer DES

30 Aug 2023

Alex Sticchi provides his take on the 3-year results of HOST-POLYTECH-ACS RCT which were presented by Hyo-Soo Kim during the ESC 2023 congress in Amsterdam.

Alessandro Sticchi

Author

Alessandro Sticchi
Three-year results of HOST-POLYTECH-ACS RCT comparing durable- vs. degradable-polymer DES

5 year results from the COMPARE-ABSORB trial

27 Aug 2023

Mirvat Alasnag and Pieter C Smits discuss the design of the randomised controlled trial COMPARE-ABSORB and the 5-year results which he presented during the ESC Congress 2023 in Amsterdam.

Dr. Mirvat Alasnag

Author

Mirvat Alasnag

Author

Pieter Smits
5 year results from the COMPARE-ABSORB trial

ILUMIEN IV: OPTIMAL PCI - Optical Coherence Tomography Guided Coronary Stent Implantation Compared with Angiography: A Multicenter Randomized Trial in Percutaneous Coronary Intervention

29 Aug 2023

Claudio Laudani and Daniele Giacoppo report the main results of the ILUMIEN IV trial presented by Ziad Ali, from the St. Francis Hospital, Roslyn, and Clinical Trials Center, Cardiovascular Research Foundation, New York, in a Hot Line session at the European Society of Cardiology congress 2023...

Claudio Laudani

Author

Claudio Laudani
Daniele Giacoppo

Author

Daniele Giacoppo
ILUMIEN IV: OCT versus angiography

P2Y12 inhibitor monotherapy vs DAPT after PCI with BP-EES: The SHARE Randomized Clinical Trial

26 Aug 2023

Elad Asher provides his take on the final results of the SHARE (SHort-term Dual Antiplatelet Therapy After Deployment of BioabsoRbable Polymer Everolimus-Eluting Stent) trial, which were presented during the ESC 2023 congress in Amsterdam by Pil-Ki Min.

Elad Asher

Author

Elad Asher
SHARE trial: P2Y12 inhibitor monotherapy vs DAPT after PCI

The GUIDE-DES Trial - QCA versus IVUS guidance for DES implantation

27 Aug 2023

Quantitative coronary angiography-guidance versus intravascular ultrasound-guidance for drug-eluting stent implantation (GUIDE-DES trial): A multicenter, non-inferiority, randomised-controlled trial

Nicola Ryan provides her take on the final results of GUIDE-DES which were presented by Taeoh Kim during the ESC 2023 congress in Amsterdam.

Note the assumptions in this article are based on the presentation...

Nicola Ryan

Author

Nicola Ryan
The GUIDE-DES Trial - QCA versus IVUS guidance for DES implantation